Williams Brinkley Ruth — SEC Form 4 filings

SEC reporting owner CIK 1344381. 9 Form 4 filings on record with FilingPulse; latest filed 2026-05-21.

Transaction summary — filings shown

Covers all 9 filings on record, filed 2024-05-10 to 2026-05-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Natera, Inc. (NTRA)Director66
Travere Therapeutics, Inc. (TVTX)Director36

Form 4 filings — Williams Brinkley Ruth

FiledFormIssuerReported transactionsSource
2026-05-214Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2026-04-284Natera, Inc. (NTRA)Grant/award (A): 86EDGAR
2026-02-034Natera, Inc. (NTRA)Grant/award (A): 73EDGAR
2025-11-044Natera, Inc. (NTRA)Grant/award (A): 97EDGAR
2025-07-294Natera, Inc. (NTRA)Grant/award (A): 112EDGAR
2025-07-014Natera, Inc. (NTRA)Grant/award (A): 2,143EDGAR
2025-05-164Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2024-07-024Natera, Inc. (NTRA)Grant/award (A): 2,964EDGAR
2024-05-104Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1344381 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →